| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| ARXAccelerant Holdings | 1.76B | 15.37 | 109.79 | 79.61% | -170.42% | -199.4% | 42.65% | 0.28 |
| Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|
| Revenue | 103.2M | 213.1M | 325.5M | 584.64M |
| Revenue Growth % | - | 1.06% | 0.53% | 0.8% |
| Medical Costs & Claims | 39.7M | 134.5M | 130.2M | 248.7M |
| Medical Cost Ratio % | - | - | - | - |
| Gross Profit | 63.5M | 78.6M | 195.3M | 335.94M |
| Gross Margin % | - | - | - | - |
| Gross Profit Growth % | - | 0.24% | 1.48% | 0.72% |
| Operating Expenses | 83.5M | 162.9M | 239.2M | 303.7M |
| OpEx / Revenue % | - | - | - | - |
| Depreciation & Amortization | 1.6M | 5.8M | 14.5M | 26.6M |
| Combined Ratio % | - | - | - | - |
| Operating Income | -20M | -84.3M | -43.9M | 32.24M |
| Operating Margin % | - | - | - | - |
| Operating Income Growth % | - | -3.21% | 0.48% | 1.73% |
| EBITDA | -18.4M | -78.5M | -29.4M | 58.84M |
| EBITDA Margin % | - | - | - | - |
| Interest Expense | 2.9M | 4.2M | 10.9M | 19.1M |
| Non-Operating Income | -2.9M | -4.2M | -10.9M | -19.1M |
| Pretax Income | -20M | -84.3M | -43.9M | 32.24M |
| Pretax Margin % | - | - | - | - |
| Income Tax | 4.3M | 11.3M | 20.2M | 9.1M |
| Effective Tax Rate % | - | - | - | - |
| Net Income | -21.5M | -91.7M | -48.8M | 27.2M |
| Net Margin % | - | - | - | - |
| Net Income Growth % | - | -3.27% | 0.47% | 1.56% |
| EPS (Diluted) | -0.10 | -0.55 | -0.29 | 0.14 |
| EPS Growth % | - | -4.54% | 0.47% | 1.48% |
| EPS (Basic) | -0.13 | -0.55 | -0.29 | 0.16 |
| Diluted Shares Outstanding | 216.67M | 165.6M | 165.6M | 199.66M |
| Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|
| Total Assets | 1.16B | 2.2B | 3.74B | 6.09B |
| Asset Growth % | - | 0.9% | 0.7% | 0.63% |
| Total Investment Assets | 150M | 273.4M | 247.5M | 602.9M |
| Long-Term Investments | 146.9M | 260.5M | 239.5M | 538.1M |
| Short-Term Investments | 38.2M | 62.8M | 8M | 64.8M |
| Total Current Assets | 0 | 0 | 3.28B | 5.25B |
| Cash & Equivalents | 301.9M | 446.2M | 775.4M | 1.23B |
| Receivables | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | -909.5M | -1.81B | 223.4M | 214.6M |
| Goodwill & Intangibles | 59.3M | 93.1M | 120.6M | 147.6M |
| Goodwill | 12.6M | 18.3M | 20.7M | 30.9M |
| Intangible Assets | 46.7M | 74.8M | 99.9M | 116.7M |
| PP&E (Net) | 0 | 0 | 0 | 0 |
| Other Assets | -206.2M | -353.6M | 93M | 157.5M |
| Total Liabilities | 899.4M | 1.85B | 3.45B | 5.67B |
| Total Debt | 49.9M | 100.5M | 120.3M | 121.4M |
| Net Debt | -252M | -345.7M | -655.1M | -1.1B |
| Long-Term Debt | 49.9M | 100.5M | 120.3M | 120.6M |
| Short-Term Debt | 0 | 0 | 0 | 800K |
| Total Current Liabilities | 0 | 0 | 101.1M | 541.8M |
| Accounts Payable | 192.2M | 277.4M | 9.5M | 13.8M |
| Deferred Revenue | 30.2M | 84.5M | 0 | 0 |
| Other Current Liabilities | -296.6M | -461M | 0 | 425.5M |
| Deferred Taxes | 0 | 0 | 0 | 0 |
| Other Liabilities | -49.9M | -100.5M | 3.23B | 5.01B |
| Total Equity | 256.1M | 350M | 286.7M | 427M |
| Equity Growth % | - | 0.37% | -0.18% | 0.49% |
| Shareholders Equity | 257.9M | 354.5M | 310.5M | 408.7M |
| Minority Interest | -1.8M | -4.5M | -23.8M | 18.3M |
| Retained Earnings | -69.5M | -161.2M | -210M | -182.8M |
| Common Stock | 0 | 0 | 0 | 0 |
| Accumulated OCI | 8.1M | -10.9M | -7.5M | -19.5M |
| Return on Equity (ROE) | -0.08% | -0.3% | -0.15% | 0.08% |
| Return on Assets (ROA) | -0.02% | -0.05% | -0.02% | 0.01% |
| Equity / Assets | - | - | - | - |
| Debt / Equity | 0.19x | 0.29x | 0.42x | 0.28x |
| Book Value per Share | 1.18 | 2.11 | 1.73 | 2.14 |
| Tangible BV per Share | - | - | - | - |
| Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|
| Cash from Operations | 112.7M | 65.7M | 289.9M | 785.5M |
| Operating CF Growth % | - | -0.42% | 3.41% | 1.71% |
| Operating CF / Revenue % | - | - | - | - |
| Net Income | -24.4M | -96.4M | -64.1M | 22.4M |
| Depreciation & Amortization | 1.6M | 5.8M | 14.5M | 26.6M |
| Stock-Based Compensation | 0 | 0 | 4.8M | 8.4M |
| Deferred Taxes | -1.7M | -5.8M | 300K | -40.9M |
| Other Non-Cash Items | 9.5M | 4.2M | -22.1M | -32.1M |
| Working Capital Changes | 127.7M | 157.9M | 356.5M | 801.1M |
| Cash from Investing | -132.5M | -147.5M | -11.7M | -380.1M |
| Capital Expenditures | -14.7M | -26.7M | -32.6M | -34.4M |
| Acquisitions | -21.2M | -11.2M | 2.2M | -4.8M |
| Purchase of Investments | -125.4M | -263.5M | -122M | -557.6M |
| Sale/Maturity of Investments | 1000K | 1000K | 1000K | 1000K |
| Other Investing | -100K | 600K | -100K | -1.3M |
| Cash from Financing | 233.7M | 254.7M | 10.3M | 110.3M |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 |
| Stock Issued | 30.9M | 0 | 0 | 0 |
| Debt Issuance (Net) | 1000K | 1000K | 1000K | -700K |
| Other Financing | 0 | -1.4M | -8.4M | -3.5M |
| Net Change in Cash | 216.1M | 158.3M | 291.8M | 497.4M |
| Exchange Rate Effect | 1000K | -1000K | 1000K | -1000K |
| Cash at Beginning | 85.8M | 325.7M | 484M | 775.8M |
| Cash at End | 301.9M | 484M | 775.8M | 1.27B |
| Free Cash Flow | 98M | 39M | 257.3M | 751.1M |
| FCF Growth % | - | -0.6% | 5.6% | 1.92% |
| FCF Margin % | - | - | - | - |
| FCF per Share | 0.45 | 0.24 | 1.55 | 3.76 |
| Metric | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Combined Ratio | 119.38% | 139.56% | 113.49% | 94.49% |
| Medical Cost Ratio | 38.47% | 63.12% | 40% | 42.54% |
| Return on Equity (ROE) | -8.4% | -30.26% | -15.33% | 7.62% |
| Return on Assets (ROA) | -1.86% | -5.47% | -1.64% | 0.55% |
| Equity / Assets | 22.16% | 15.92% | 7.67% | 7.01% |
| Book Value / Share | 1.18 | 2.11 | 1.73 | 2.14 |
| Debt / Equity | 0.19x | 0.29x | 0.42x | 0.28x |
| Revenue Growth | - | 106.49% | 52.75% | 79.61% |
Accelerant Holdings (ARX) has a price-to-earnings (P/E) ratio of 109.8x. This suggests investors expect higher future growth.
Accelerant Holdings (ARX) grew revenue by 79.6% over the past year. This is strong growth.
Accelerant Holdings (ARX) reported a net loss of $1.40B for fiscal year 2024.
Accelerant Holdings (ARX) has a return on equity (ROE) of 7.6%. This is below average, suggesting room for improvement.
Accelerant Holdings (ARX) has a combined ratio of 94.5%. A ratio below 100% indicates underwriting profitability.